< iframe width =" 425" height=" 355 "src= "https://www.youtube.com/embed/AlPVFMDCOY0?rel=0" frameborder=" 0" allowfullscreen > Jennifer L. Costello, PharmD, BCPS, BC-ADM, ambulatory treatment medical pharmacist at Saint Barnabas Medical Center, evaluates the pharmacologic mechanisms in the new weight-loss drugs. Liraglutide, a glucagon-like peptide-1 receptor agonist, helps boost insulin secretion and decrease glucagon release. The drug drastically affects […]
Continue reading…